Canada Research Roundup: Aphria, Maverix Metals, Versapay

Viemed Healthcare

24/05/2019 12:44

May 24 (Reuters) - Securities analysts revised their ratings and price targets on several
Canadian companies, including Aphria, Maverix Metals and Versapay, on Friday.    
    
  HIGHLIGHTS
     * Aphria Inc  APHA.TO : Jefferies starts with buy rating; price target C$15
     * Maverix Metals Inc  MMX.V : Raymond James raises target price to C$5.50 from C$2.75
     * Versapay Corp  VPY.V : Eight Capital raises target price to C$2.50 from C$2
 Following is a summary of research actions on Canadian companies reported by Reuters on Friday.
Stock entries are in alphabetical order. 

     * Aphria Inc  APHA.TO : Jefferies starts with buy rating; price target C$15
     * Canntrust Holdings  TRST.TO : BofA Merrill starts with buy rating; price objective C$11
     * Heroux Devtek Inc  HRX.TO : Raymond James raises target price to C$19.50 from C$17
     * Maverix Metals Inc  MMX.V : Raymond James raises target price to C$5.50 from C$2.75
     * Prairiesky Royalty Ltd  PSK.TO : Raymond James raises target price to C$20.50 from C$20
     * Prairiesky Royalty Ltd  PSK.TO : RBC cuts price target to C$24 from C$26
     * Premium Brands Holdings Corp  PBH.TO : CIBC raises price target to C$84 from C$76
     * Pure Multi-Family REIT LP  RUF_u.TO : BMO raises target price to C$7.30 from C$7.15
     * Royal Bank of Canada  RY.TO : BMO raises target price to C$114 from C$110
     * Toronto-Dominion Bank  TD.TO : BMO raises target price to C$85 from C$82
     * Toronto-Dominion Bank  TD.TO : CIBC raises price target to C$85 from C$84
     * Versapay Corp  VPY.V : Eight Capital raises target price to C$2.50 from C$2
     * Viemed Healthcare  VMD.TO : Acumen Capital initiates coverage with buy rating, C$12 TP
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))